First Trust Advisors LP Brainstorm Cell Therapeutics Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.14 - $4.09 $234,529 - $305,486	-74,691 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.01 - $4.01 $4,277 - $5,698	-1,421 Reduced 1.87%	74,691 $284,000
Q1 2021 May 14, 2021	BUY	$3.46 - $7.88 $49,298 - $112,274	14,248 Added 23.03%	76,112 $292,000
Q4 2020 Feb 02, 2021	SELL	$3.99 - $17.73 $10,828 - $48,119	-2,714 Reduced 4.2%	61,864 $280,000
Q3 2020 Nov 05, 2020	BUY	$11.19 - $16.92 $722,627 - $1.09 Million	64,578 New	64,578 $1.09 Million

10.5M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $69.3M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.